Crossref
Empagliflozin-Mediated Cardiorenal Protection Beyond Glycemic Control: Experimental Evidence, Clinical Outcomes, and Potential Mechanisms
Alexandria Journal of Veterinary Sciences · 2026
DOI: 10.5455/ajvs.333549 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alexandria Journal of Veterinary Sciences, 2026. Die Arbeit nennt 1040 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Empagliflozin-Mediated Cardiorenal Protection Beyond Glycemic Control: Experimental Evidence, Clinical Outcomes, and Potential Mechanisms. Alexandria Journal of Veterinary Sciences. https://doi.org/10.5455/ajvs.333549
Vancouver
Empagliflozin-Mediated Cardiorenal Protection Beyond Glycemic Control: Experimental Evidence, Clinical Outcomes, and Potential Mechanisms. Alexandria Journal of Veterinary Sciences. 2026. doi:10.5455/ajvs.333549
BibTeX
@article{euvimed2026,
title = {Empagliflozin-Mediated Cardiorenal Protection Beyond Glycemic Control: Experimental Evidence, Clinical Outcomes, and Potential Mechanisms},
journal = {Alexandria Journal of Veterinary Sciences},
year = {2026},
doi = {10.5455/ajvs.333549}
}
EUVIMED